Characteristics of childhood tuberculosis;Besonderheiten der Kindertuberkulose

Pneumologie

Volumn 63, Issue 4, 2009, Pages 207-218

  Detjen, A K ^a,b   Magdorf, K ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; CONTRACEPTIVE AGENT; COUMARIN DERIVATIVE; CYCLOSPORIN; DIGITOXIN; ETHAMBUTOL; ISONIAZID; ORAL ANTIDIABETIC AGENT; PROPRANOLOL; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THEOPHYLLINE; ZIDOVUDINE;

ACUTE HEPATITIS; ARTHRALGIA; CHILDHOOD DISEASE; DISEASE TRANSMISSION; FATALITY; GASTROINTESTINAL SYMPTOM; HEPATITIS; HUMAN; HYPERURICEMIA; INDUSTRIALIZATION; INFECTION; INFECTION RISK; LIVER DISEASE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NEPHROTOXICITY; NEUROTOXICITY; OPTIC NEURITIS; OTOTOXICITY; PRIORITY JOURNAL; PRURITUS; REVIEW; SIDE EFFECT; TUBERCULOSIS; CHILD; CLINICAL TRIAL;

CHILD; CLINICAL TRIALS AS TOPIC; HUMANS; TUBERCULOSIS;

EID: 65349178129     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-0028-1100827     Document Type: Review

References (100)

1. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994; 72: 213-220 (Pubitemid 24156209)
2. Rekha B, Swaminathan S. Childhood tuberculosis - global epidemiology and the impact of HIV. Ped Respir Rev 2007; 8: 99-106
3. Jereb JA, Kelly GD, Porterfield DS. The epidemiology of tuberculosis in children. Sem Pediatr Infect Dis 1993; 4: 220-231
4. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004; 8: 636-647
5. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing: WHOreport 2008. Geneva: World Health Organization (WHO/HTM/TB/2008.393), 2008
6. Clancy L, Rieder HL, Enarson DA et al. Tuberculosis elimination in the countries of Europe and other industrialized countries. Eur Respir J 1991; 4: 1288-1295
7. Robert Koch Institut. Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2006. Berlin: Robert Koch Institut, 2008
8. World Health Organization. Anti Tuberculosis Drug Resistance in the World. Report No.4. Geneva: World Health Organization (WHO/ HTM/TB/2008.394), 2008
9. World Health Organization. Extensively drugresisant tuberculosis (XDRTB): Recommendations for prevention and control. Wkly Epi demiol Rec 2006; 81: 430-432
10. Cardona M, Bek MD, Mills K et al. Transmission of tuberculosis from a sevenyearold child in a Sydney school. J Paediatr Child Health 1999; 35: 375-378
11. Donald PR, Fourie PB, Grange JM. Tuberculosis in childhood. JL van Schalk Publishers, 1999
12. Loudon RG, Spohn SK. Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Respir Dis 1969; 99: 109-111
13. Corbett EL, Watt CJ, Walker N et al. The growing burden of tuberculosis. Global Trends and Interactions with the HIV Epidemic. Arch in tern Med 2003; 163: 1009-1021
14. Aaron L, Saadoun D, Calantroni I et al. Tuberculosis in HIVinfected patients: a comprehensive review. Clin Microbiol Infect 2004; 10: 388-398
15. Marais BJ, Gie RP, Schaaf HS et al. The Natural History of childhood in trathoracic tuberculosis: a critical review of literature from the prechemotherapy era. Int J Tuberc Lung Dis 2006; 8: 392-402
16. Schlossberg D. Tuberculosis and nontuberculous mycobacterial infections. Fifth Edition. McGraw Hill Companies, 2006
17. Jacobsen M, Detjen A, Mueller H et al. Clonal expansion of CD8+ effector T cells in childhood tuberculosis. J Immunol 2007; 179: 1331- 1339
18. Casanova JL, Abel L. The Human Model: A genetic dissection of im munity to infection in natural conditions. Nature Reviews Immunology 2004; 4: 55-66
19. Ulrichs T, Kaufmann SHE. Immunology and Persistence. Issues Infect Dis 2003; 2: 112-127
20. Feja K, Saiman L. Tuberculosis in children. Clin Chest Med 2005; 26: 295-312
21. Marais BJ, Gie RP, Schaaf HS et al. A proposed radiological classifica tion of childhood intrathoracic tuberculosis. Pediatr Radiol 2004; 34: 886-894
22. Cruz AT, Starke JR. Clinical manifestations of tuberculosis in children. Paed Respir Rev 2007; 8: 107-117
23. Romanus V, Hallander H, Wahlen P et al. Atypicalmycobacteria in ex trapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCGvaccination. Tuber Lung Dis 1995; 76: 300-310
24. WiesePosselt M, Siedler A, Rademacher A et al. ESPID Study Group 2: incidence of nontuberculous mycobacteria (NTM) in children aged<15 years, Germany 2002-2004. Tampere, Finland: ESPID Annual Meeting, May 2004
25. Haverkamp MH, Arend SM, Lindeboom JA et al. Nontuberculousmyco bacterial infection in children: A 2year prospective surveillance study in the Netherlands. Clin Infect Dis 2004; 39: 450-456
26. Thegerström J, Friman V, Nylen O et al. Clinical features and incidence of Mycobacterium avium infections in children. Scand J Infect Dis 2008; 40: 481-486
27. Lindeboom JA, Kuijper EJ, Bruijnesteijn van Coppenraet ES et al. Surgi cal excision versus antibiotic treatment for nontuberculous myco bacterial cervicofacial lymphadenitis in children: A Multicenter, Randomized, Controlled Trial. Clin Infect Dis 2007; 44: 1057-1064
28. Griffith DE, Aksamit T, BrownElliott BA et al. An official ATS/IDSA sta tement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367- 416
29. Wallgren A. The timetable of tuberculosis. Tubercle 1948; 29: 245- 251
30. Schoeman J, Mansvelt E, Springer P et al. Coagulant and fibrinolytic status in tuberculous meningitis. Pediatr Infect Dis J 2007; 26: 428-431
31. Medical Research Council Streptomycin in Tuberculosis Trials Commit tee. Streptomycin treatment in tuberculous meningitis. Lancet 1948; 1: 582-597
32. Rock RB, Olin M, Baker CA et al. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev 2008; 21: 243- 261
33. Schoeman JF, Van Zyl LE, Laubscher JA et al. Serial CT scanning in childhood tuberculous meningitis: prognostic features in 198 cases. J Child Neurol 1995; 10: 320-329
34. Schoeman J, Wait J, Burger M et al. Longterm follow up of childhood tuberculous meningitis. Dev Med Child Neurol 2002; 44: 522-526
35. Sharma SK, Mohan A, Sharma A et al. Miliary Tuberculosis: New In sights Into an Old Disease. Lancet Infect Dis 2005; 5: 415-430
36. Connelly Smith K. Congenital tuberculosis: a rare manifestation of a common infection. Curr Opin Infect Dis 2002; 15: 269-274
37. Cantwell MF, Shehab ZM, Costello AM et al. Congenital Tuberculosis. New Engl J Med 1994; 330: 1051-1054
38. Ormerod P. Tuberculosis in pregnancy and the puerperium. Thorax 2001; 56: 494-499
39. Ozuah PO, Ozuah TP, Stein REK et al. Evaluation of a risk assessment questionnaire used to target tuberculin skin testing in children. JAMA 2001; 285: 451-453
40. Magdorf K, Detjen AK. Proposed management of childhood tubercu losis in lowincidence countries. Eur J Pediatr 2008; 167: 927- 938 Epub 2008 May 10
41. Magdorf K. Tuberkulose und nichttuberkulöse mykobakterielle Krankheiten. In: DGPI Handbuch, Infektionen bei Kindern und Ju gendlichen. 4.Auflage. München: Futuramed Verlag, 2003: 699-719
42. Sagebiel D, Magdorf K, Loddenkemper R. Aktuelle Information des DZK zur Tuberkulinversorgung Deutschlands. Pneumologie 2005; 59: 236-237
43. American Thoracic Society, Centers for Disease Control and Prevention. Targeted tuberculin testing, and treatment of latent tuberculosis in fection. Am J Respir Crit Care Med 2000; 161: 221-247
44. Magdorf K. Tuberkulose im Kindesalter - Pathogenese, Prävention, Klinik und Therapie. Monatsschr Kinderheilk 2006; 154: 124-132
45. HaimiCohen Y. Skin indurations in response to tuberculin testing in patients with nontuberculous mycobacterial lymphadenitis. Clin In fect Dis 2001; 33: 1786-1788
46. Pai M, Zwerling A, Menzies D. Systematic review: Tcellbased assays for the diagnosis of latent tuberculosis infection: an update. Ann In tern Med 2008; 149 [Epub ahead of print]
47. Pai M, Menzies D. Interferongamma release assays: what is their role in the diagnosis of active tuberculosis Clin Infect Dis 2007; 44: 74- 77
48. Detjen AK, Keil T, Roll S et al. Interferong release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin In fect Dis 2007; 45: 322-328
49. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert re view of molecular diagnostics 2006; 6: 413-422 (Pubitemid 44174345)
50. Karam F, Mbow F, Fletcher H et al. Sensitivity of IFNgamma release assay to detect latent tuberculosis infection is retained in HIVin fected patients but dependent on HIV/AIDS progression. PLoS ONE 2008; 3: e1441
51. Liebeschuetz S, Bamber S, Ewer K et al. Diagnosis of tuberculosis in South African children with a Tcellbases assay: a prospective co hort study. Lancet 2004; 365: 97-98
52. Mandalakas AM, Hesseling AC, Chegou NN et al. High level of discor dant IGRA results in HIVinfected adults and children. Int J Tuberc Lung Dis 2008; 12: 417-423
53. Menzies D, Pai M, Comstock G. Metaanalysis: new tests for the diag nosis of latent tuberculosis infection: areas of uncertainty and re commendations for research. Ann Intern Med 2007; 146: 350-354
54. Diel R, Loddenkemper R, MeywaldWalter K et al. Predictive value of a whole blood IFNgamma assay for the development of active tuber culosis disease after recent infection with Mycobacterium tubercu losis. Am J Respir Crit Care Med 2008; 177: 1164-1170
55. Hill PC, JacksonSillah DJ, Fox A et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case con tacts. PLoS ONE 2008; 3: e1379
56. Mazurek GH, Jereb J, Lobue P et al. Guidelines for using QuantiFERON TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54: 49-55
57. National Institute for Health and Clinical Excellence. Tuberculosis: cli nical diagnosis and management of tuberculosis, and measures for its prevention and control. Available at: www.nice.org.uk, 2006
58. Haute Autoritø de santø. Test de døtøction de la production d'interfe rong pour le diagnosis des infection tuberculeuses. Available at: www.hassant/.fr, 2006
59. Diel R, Nienhaus A, Lange C et al. Costoptimization of screening for latent tuberculosis in close contacts. Eur Respir J 2006; 28: 35-44 (Pubitemid 44914258)
60. Diel R, Forssbohm M, Loytved G et al. Empfehlungen für die Umge bungsuntersuchungen bei Tuberkulose. Pneumologie 2007; 61: 440-455
61. Canadian Tuberculosis Committee. Interferon gamma release assays for latent tuberculosis infection. Canada Communicable Disease Re port, 2007
62. Doherty TM, Demissie A, Menzies D et al. VACSEL Study Group. Effect of sample handling on analysis of cytokine responses to Mycobacte rium tuberculosis in clinical samples using ELISA, ELISPOT and quan titative PCR. J Immunol Meth 2005; 298: 129-141
63. Meier T, Eulenbruch HP, WrightonSmith P et al. Sensitivity of a new commercial enzymelinked immunospot assay (T SPOTTB) for diag nosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 2005; 24: 529-536
64. Dinnes J, Deeks J, Kunst H et al. A systematic review of rapid diagnos tic tests for the detection of tuberculosis. Health Technol Assess 2007; 11: 1-196
65. RüschGerdes S, Hillemann D. Moderne mykobakteriologische Labor diagnostik. Pneumologie 2008; 62: 533-540
66. Zar HJ, Hanslo D, Apolles P. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 2005; 365: 130- 134
67. Starke JR. Pediatric tuberculosis: time for a new approach. Tubercu losis 2003; 5: 594-603
68. Steingart KR, Henry M, Hopewell PC et al. Fluorescence versus con ventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006; 6: 570-581 (Pubitemid 44262344)
69. Marais BJ, Hesseling AC, Gie RP et al. The bacteriologic yield in chil dren with intrathoracic tuberculosis. Clin Infect Dis 2006; 42: 69-71
70. Ling DI, Flores LL, Riley LW et al. Commercial nucleicacid amplifica tion tests for diagnosis of pulmonary tuberculosis in respiratory spe cimens: metaanalysis and metaregression. PLoS ONE 2007; 3 (2): e1536 doi 0.1371/journal.pone.0001536
71. Steingart KR, Henry M, Laal S et al. Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a syste matic review. PLoS Med 2007; 4: e202
72. World Health Organization. Guidance for national tuberculosis pro grammes on the management of tuberculosis in children. 2006 WHO/HTM/ TB/2006.371
73. Broekmans JF, Migliori GB, Rieder HL et al. European framework for tuberculosis control and elimination in countries with a low inci dence. Eur Respir J 2002; 19: 765-775
74. Colditz GA, Berkey CS, Mosteller F et al. The efficacy of bacillus Calmet teGuørin vaccination of newborns and infants in the prevention of tuberculosis: metaanalyses of the published literature. Pediatrics 1995; 96: 29-35
75. Davies PDO. Clinical Tuberculosis. Arnold Publishers. Third Edition, 2003
76. Soysal A, Millington KA, BakirMet al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective communitybased study. Lancet 2005; 366: 1443-1451
77. Infuso A, Falzon D. European survey of BCG vaccination policies and surveillance in children, 2005. Euro Surveill 2006; 11: 6-11
78. Ständige Impfkommission am Robert Koch Institut. Impfempfehlun gen der Ständigen Impfkommission (STIKO) Stand März 1998. Epide miologisches Bulletin. Robert Koch Institut, 15/98: 101-112
79. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose. Richtlini en zur medikamentösen Behandlung der Tuberkulose im Erwachse nen und Kindesalter. Pneumologie 2001; 55: 494-511
80. Comstock GW, Caras GJ, Koplan JP. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults Int J Tuberc Lung Dis 1999; 3: 847-850
81. Ormerod LP. Rifampicin ad isoniazide prophylactic chemotherapy for tuberculosis. Arch Dis Child 1998; 78: 169-171
82. Ena J, Valls V. Shourt course therapy with rifampicin plus isonoazid, compared with standard therapy with isoniazid for latent tuberculo sis infection: a metaanalysis. Clin Infect Dis 2005; 40: 670-676
83. Rennie TW, Bothamley GH, Engova D et al. Patient choice promotes adherence in preventive treatment for latent tuberculosis. Eur Respir J 2007; 30: 728-735
84. Spyridis NP, Spyridis PG, Gelesme A et al. The effectiveness of a 9month regimen of isoniazid alone versus 3 and 4month re gimens of isoniazid plus rifampin for treatment of latent tuberculo sis infection in children: results of an 11year randomized study. Clin Infect Dis 2007; 45: 715-722
85. Thee S, Detjen AK, Quarcoo D et al. Ethambutol in paediatric tubercu losis: aspects of ethambutol serum concentration, efficacy and toxi city in children. Int J Tuberc Lung Dis 2007; 11: 965-971
86. Thee S, Detjen AK, Wahn U et al. Pyrazinamide serum levels in child hood tuberculosis. Int J Tuberc Lung Dis 2008; 12: 1099-1101
87. American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Disease society of America. Treatment of tuberculosis. Am J Resp Crit Care Med 2003; 167: 63-662
88. Ellard GA, Humphries MJ, Allen BW. Cerebrospinal fluid drug concen trations and the treatment of tuberculous meningitis. Am Rev Respir Dis 1993; 148: 650-655
89. Donald PR, Seifart HI. Cerebrospinal fluid concentrations of ethion amide in children with tuberculous meningitis. J Pediatr 1989; 115: 483-486
90. Prasad K, Volmink J, Menon GR. Steroids for treating tuberculous me ningitis. The Cochrane Database of Systematic Reviews, 2000, Issue 3. Art. No.: CD0022 44. DOI: 10.1002/14651858.CD002244
91. Schoeman JF, Van Zyl LE, Laubscher JA et al. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 1997; 99: 226-231
92. Thwaites GE, MacmullenPrice J, Tran TH et al. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tubercu lous meningitis: an observational study. Lancet Neurol 2007; 6: 230-236
93. Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis 1997; 25: 872-887
94. Jain AK, Dhammi IK. Tuberculosis of the spine: a review. Clin Orthop Relat Res 2007; 460: 39-49
95. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: A general review. Bibl Tuberc 1970; 26: 28-106
96. Otto HS, Magdorf K. Aktueller Stand der antituberkulösen Chemothe rapie im Kindesalter. Prax Pneumol 1981; 35: 588-595
97. Ravenscroft A, Schoeman JF, Donald PR. Tuberculous granulomas in childhood tuberculous meningitis: radiological features and course. J Trop Pediatr 2001; 47: 5-12
98. Schoeman JF, Fieggen G, Seller N et al. Intractable intracranial tubercu lous infection responsive to thalidomide: report of four cases. J Child Neurol 2006; 21: 301-308
99. Sneag DB, Schaaf HS, Cotton MF et al. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multi drugresistant tuberculosis. Pediatr Infect Dis J 2007; 26: 1142-1146
100. Katiyar SK, Bihari S, Prakash S et al. A randomized controlled trial of highdose isoniazid adjuvant therapy for multidrugresistant tuber culosis. Int J Tuberc Lung Dis 2008; 12: 139-145